Search

Your search keyword '"Eason, James D."' showing total 313 results
Start Over Author "Eason, James D."
313 results on '"Eason, James D."'

2. History of posttraumatic stress disorder and outcomes after kidney transplantation.

Author

Siwakoti, Ashmita, Potukuchi, Praveen K, Thomas, Fridtjof, Gaipov, Abduzhappar, Talwar, Manish, Balaraman, Vasanthi, Cseprekal, Orsolya, Yazawa, Masahiko, Streja, Elani, Eason, James D, Kalantar-Zadeh, Kamyar, Kovesdy, Csaba P, and Molnar, Miklos Z

Subjects
Humans, Kidney Failure, Chronic, Postoperative Complications, Kidney Function Tests, Glomerular Filtration Rate, Prognosis, Kidney Transplantation, Cause of Death, Survival Rate, Risk Factors, Retrospective Studies, Follow-Up Studies, Stress Disorders, Post-Traumatic, Graft Rejection, Graft Survival, Middle Aged, Veterans, Female, Male, Medication Adherence, clinical research/practice, epidemiology, graft survival, health services and outcomes research, kidney transplantation/nephrology, patient survival, Transplantation, Kidney Disease, Mental Health, Post-Traumatic Stress Disorder (PTSD), Clinical Research, Brain Disorders, Organ Transplantation, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Renal and urogenital, Good Health and Well Being, clinical research, practice, kidney transplantation, nephrology, Medical and Health Sciences, Surgery
Abstract

A history of posttraumatic stress disorder (PTSD), if uncontrolled, represents a contraindication for kidney transplantation. However, no previous large study has assessed the association between pretransplant history of PTSD and posttransplantation outcomes. We examined 4479 US veterans who had undergone transplantation. The diagnosis of history of PTSD was based on a validated algorithm. Measured covariates were used to create a matched cohort (n = 560). Associations between pretransplant PTSD and death with functioning graft, all-cause death, and graft loss were examined in survival models. Posttransplant medication nonadherence was assessed using proportion of days covered (PDC). From among 4479 veterans, 282 (6.3%) had a history of PTSD. The mean age ± standard deviation (SD) of the cohort at baseline was 61 ± 11 years, 91% were male, and 66% and 28% of patients were white and African American, respectively. Compared to patients without a history of PTSD, patients with a history of PTSD had a similar risk of death with a functioning graft (subhazard ratio [SHR] 0.97, 95% confidence interval [CI] 0.61-1.54), all-cause death (1.05, 0.69-1.58), and graft loss (1.09, 0.53-2.26). Moreover, there was no difference in immunosuppressive drug PDC in patients with and without a history of PTSD (PDC: 98 ± 4% vs 99 ± 3%, P = .733 for tacrolimus; PDC: 99 ± 4% vs 98 ± 7%, P = .369 for mycophenolic acid). A history of PTSD in US veterans with end-stage renal disease should not on its own preclude a veteran from being considered for transplantation.

Published
2019

4. Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation

Author

Molnar, Miklos Z., Potluri, Vishnu S., Schaubel, Douglas E., Sise, Meghan E., Concepcion, Beatrice P., Forbes, Rachel C., Blumberg, Emily, Bloom, Roy D., Shaffer, David, Chung, Raymond T., Strohbehn, Ian A., Elias, Nahel, Azhar, Ambreen, Shah, Mital, Sawinski, Deirdre, Binari, Laura A., Talwar, Manish, Balaraman, Vasanthi, Bhalla, Anshul, Eason, James D., Besharatian, Behdad, Trofe-Clark, Jennifer, Goldberg, David S., and Reese, Peter P.

Published
2022
Full Text
View/download PDF

5. History of psychosis and mania, and outcomes after kidney transplantation ‐ a retrospective study

Author

Molnar, Miklos Z, Eason, James D, Gaipov, Abduzhappar, Talwar, Manish, Potukuchi, Praveen K, Joglekar, Kiran, Remport, Adam, Mathe, Zoltan, Mucsi, Istvan, Novak, Marta, Kalantar‐Zadeh, Kamyar, and Kovesdy, Csaba P

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Brain Disorders, Transplantation, Clinical Research, Organ Transplantation, Kidney Disease, Renal and urogenital, Good Health and Well Being, Aged, Bipolar Disorder, Cause of Death, Female, Graft Rejection, Humans, Kidney Transplantation, Male, Medication Adherence, Middle Aged, Psychotic Disorders, Retrospective Studies, bipolar disorder, kidney transplantation, mortality, schizophrenia, survival, Surgery, Clinical sciences
Abstract

History of psychosis or mania, if uncontrolled, both represent relative contraindications for kidney transplantation. We examined 3680 US veterans who underwent kidney transplantation. The diagnosis of history of psychosis/mania was based on a validated algorithm. Measured confounders were used to create a propensity score-matched cohort (n = 442). Associations between pretransplantation psychosis/mania and death with functioning graft, all-cause death, graft loss, and rejection were examined in survival models and logistic regression models. Post-transplant medication nonadherence was assessed using proportion of days covered (PDC) for tacrolimus and mycophenolic acid in both groups. The mean ± SD age of the cohort at baseline was 61 ± 11 years, 92% were male, and 66% and 27% of patients were white and African-American, respectively. Compared to patients without history of psychosis/mania, patients with a history of psychosis/mania had similar risk of death with functioning graft [subhazard ratio (SHR) (95% confidence interval (CI)): 0.94(0.42-2.09)], all-cause death [hazard ratio (95% CI): 1.04 (0.51-2.14)], graft loss [SHR (95% CI): 1.07 (0.45-2.57)], and rejection [odds ratio(95% CI): 1.23(0.60-2.53)]. Moreover, there was no difference in immunosuppressive drug PDC in patients with and without history of psychosis/mania (PDC: 76 ± 21% vs. 78 ± 19%, P = 0.529 for tacrolimus; PDC: 78 ± 17% vs. 79 ± 18%, P = 0.666 for mycophenolic acid). After careful selection, pretransplantation psychosis/mania is not associated with adverse outcomes in kidney transplant recipients.

Published
2018

6. Unveiling APOL1 haplotypes in a predominantly African-American cohort of kidney transplant patients: a novel classification using probe-independent quantitative real-time PCR

Author

Dogan, Murat, primary, Watkins, Christine, additional, Ingram, Holly, additional, Moore, Nicholas, additional, Rucker, Grace M., additional, Gower, Elizabeth G., additional, Eason, James D., additional, Bhalla, Anshul, additional, Talwar, Manish, additional, Nezakatgoo, Nosratollah, additional, Eymard, Corey, additional, Helmick, Ryan, additional, Vanatta, Jason, additional, Bajwa, Amandeep, additional, Kuscu, Canan, additional, and Kuscu, Cem, additional

Published
2024
Full Text
View/download PDF

7. Genome-Wide CRISPR Screen Identifies Phospholipid Scramblase 3 as the Biological Target of Mitoprotective Drug SS-31

Author

Silvaroli, Josie A., primary, Bisunke, Bijay, additional, Kim, Ji Young, additional, Stayton, Amanda, additional, Jayne, Laura A., additional, Martinez, Shirely A., additional, Nguyen, Christopher, additional, Patel, Prisha S., additional, Vanichapol, Thitinee, additional, Verma, Vivek, additional, Akhter, Juheb, additional, Bolisetty, Subhashini, additional, Madhavan, Sethu M., additional, Kuscu, Cem, additional, Coss, Christopher C., additional, Zepeda-Orozco, Diana, additional, Parikh, Samir V., additional, Satoskar, Anjali A., additional, Davidson, Alan J., additional, Eason, James D., additional, Szeto, Hazel H., additional, Pabla, Navjot Singh, additional, and Bajwa, Amandeep, additional

Published
2024
Full Text
View/download PDF

11. Exogenous mitochondrial transfer increases energy expenditure and attenuates adiposity gains in mice with diet-induced obesity

Author

Namwanje, Maria, primary, Mazumdar, Soumi, additional, Stayton, Amanda, additional, Patel, Prisha S., additional, Watkins, Christine, additional, White, Catrina, additional, Brown, Chester, additional, Eason, James D., additional, Mozhui, Khyobeni, additional, Kuscu, Cem, additional, Pabla, Navjot, additional, Stephenson, Erin J., additional, and Bajwa, Amandeep, additional

Published
2023
Full Text
View/download PDF

12. Transplantation of kidneys from hepatitis C–infected donors to hepatitis C–negative recipients: Single center experience

Author

Molnar, Miklos Z., Nair, Satheesh, Cseprekal, Orsolya, Yazawa, Masahiko, Talwar, Manish, Balaraman, Vasanthi, Podila, Pradeep S.B., Mas, Valeria, Maluf, Daniel, Helmick, Ryan A., Campos, Luis, Nezakatgoo, Nosratollah, Eymard, Corey, Horton, Peter, Verma, Rajanshu, Jenkins, Ann Holbrook, Handley, Charlotte R., Snyder, Heather S., Cummings, Carolyn, Agbim, Uchenna A., Maliakkal, Benedict, Satapathy, Sanjaya K., and Eason, James D.

Published
2019
Full Text
View/download PDF

14. Unveiling APOL1 Haplotypes: A Novel Classification Through Probe-Independent Quantitative Real-Time PCR

Author

Dogan, Murat, primary, Watkins, Christine, additional, Ingram, Holly, additional, Moore, Nicholas, additional, Rucker, Grace M., additional, Gower, Elizabeth G., additional, Eason, James D., additional, Bhalla, Anshul, additional, Talwar, Manish, additional, Nezakatgoo, Nosratollah, additional, Eymard, Corey, additional, Helmick, Ryan, additional, Vanatta, Jason, additional, Bajwa, Amandeep, additional, Kuscu, Canan, additional, and Kuscu, Cem, additional

Published
2023
Full Text
View/download PDF

17. A report of a prospective randomized trial of extended‐release tacrolimus versus immediate release tacrolimus after liver transplantation with anti‐thymocyte induction in a steroid free protocol.

Author

Helmick, Ryan A., Eymard, Corey M., Naik, Surabhi, Eason, James D., Nezakatgoo, Nosratollah, Nair, Satheesh, and Vanatta, Jason M.

Subjects
LIVER transplantation, TACROLIMUS, KIDNEY transplantation, GLOMERULAR filtration rate, QUALITY of life
Abstract

Purpose: Our study hypothesis was that once daily dosing of extended‐release tacrolimus (XRT) would be a safe and effective immunosuppression (IS) with the potential to decrease adverse events (AEs) associated with immediate release tacrolimus (IRT) after liver transplantation (LT). Methods: All patients receiving LT at our center received rabbit anti‐thymocyte globulin (RATG) induction therapy. Eligible patients were randomized in a 1:1 fashion to receive either XRT or IRT. Antimicrobial prophylaxis was the same between arms, and both groups received an antimetabolite for the first 6 months following LT. Patients were then followed at pre‐determined study intervals for the following year after LT. We administered the RAND‐36SF survey to assess patient's health‐related quality of life at pre‐determined intervals. All analysis was performed with an intention to treat basis. Results: We screened 194 consecutive patients and enrolled 110. Our control and study arms were well matched. Transplant characteristics were similar between groups. At all timepoints, both arms had similar serum creatinine and estimated glomerular filtration rate (eGFR), calculated by MDRD6 equation, with post‐transplant GFRs between 60 and 70 mL/min/1.73 m2. Tacrolimus trough levels were similar between arms. The XRT arm had fewer AEs (166) and fewer serious AEs (70) compared to IRT (201 and 99, respectively). AEs most commonly were renal, infectious, or gastrointestinal in nature. While not statistically significant, XRT was held temporarily (25 vs. 35 cases) or discontinued (3 vs. 11 cases) less frequently than IRT and had fewer instances of rejection (7 vs. 12 cases). Conclusion: This analysis showed that XRT is safe and effective as de novo maintenance IS in a steroid‐free protocol with RATG. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

21. Single-cell RNA sequencing reveals peripheral blood mononuclear immune cell landscape associated with operational tolerance in a kidney transplant recipient

Author

Azim, Shafquat, primary, Zubair, Haseeb, additional, Rousselle, Thomas, additional, McDaniels, Jennifer M., additional, Shetty, Amol C., additional, Kuscu, Cem, additional, Kuscu, Canan, additional, Talwar, Manish, additional, Eason, James D., additional, Maluf, Daniel G., additional, and Mas, Valeria R., additional

Published
2023
Full Text
View/download PDF

23. Key Hepatoprotective Roles of Mitochondria in Liver Regeneration

Author

Lamanilao, Gene G., primary, Dogan, Murat, additional, Patel, Prisha S., additional, Azim, Shafquat, additional, Patel, Disha S., additional, Bhattacharya, Syamal K., additional, Eason, James D., additional, Kuscu, Canan, additional, Kuscu, Cem, additional, and Bajwa, Amandeep, additional

Published
2023
Full Text
View/download PDF

27. CMV specific T cell immune response in hepatitis C negative kidney transplant recipients receiving transplant from hepatitis C viremic donors and hepatitis C aviremic donors

Author

Azhar, Ambreen, primary, Tsujita, Makoto, additional, Talwar, Manish, additional, Balaraman, Vasanthi, additional, Bhalla, Anshul, additional, Eason, James D., additional, Nouer, Simonne S., additional, Sumida, Keiichi, additional, Remport, Adam, additional, Hall, Isaac E., additional, Griffin, Randi, additional, Rofaiel, George, additional, and Molnar, Miklos Z., additional

Published
2022
Full Text
View/download PDF

28. Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant

Author

Markmann, James F., primary, Abouljoud, Marwan S., additional, Ghobrial, R. Mark, additional, Bhati, Chandra S., additional, Pelletier, Shawn J., additional, Lu, Amy D., additional, Ottmann, Shane, additional, Klair, Tarunjeet, additional, Eymard, Corey, additional, Roll, Garrett R., additional, Magliocca, Joseph, additional, Pruett, Timothy L., additional, Reyes, Jorge, additional, Black, Sylvester M., additional, Marsh, Christopher L., additional, Schnickel, Gabriel, additional, Kinkhabwala, Milan, additional, Florman, Sander S., additional, Merani, Shaheed, additional, Demetris, Anthony J., additional, Kimura, Shoko, additional, Rizzari, Michael, additional, Saharia, Ashish, additional, Levy, Marlon, additional, Agarwal, Avinash, additional, Cigarroa, Francisco G., additional, Eason, James D., additional, Syed, Shareef, additional, Washburn, W. Kenneth, additional, Parekh, Justin, additional, Moon, Jang, additional, Maskin, Alexander, additional, Yeh, Heidi, additional, Vagefi, Parsia A., additional, and MacConmara, Malcolm P., additional

Published
2022
Full Text
View/download PDF

29. Which cava anastomotic techniques are optimal regarding immediate and short- term outcomes after liver transplantation - A systematic review of the literature and expert panel recommendations

Author

Shaker, Tamer M, Eason, James D, Davidson, Brian R, Barth, Rolf N, Pirenne, Jacques, Imventarza, Oscar, Spiro, Michael, Raptis, Dimitri Aristotle, Fung, John, Niemann, Claus, Pollok, Joerg-Matthias, Berenguer, Marina, Tinguely, Pascale, Kathirvel, Manikandan, and Morare, Nolitha

Subjects
caval replacement, venovenous bypass, Transplantation, piggyback technique, liver transplantation, renal function, temporary portocaval shunt, cavocavostomy
Abstract

BACKGROUND: It has long been debated whether cava anastomosis should be performed with the piggyback technique or cava replacement, with or without veno-venous bypass (VVB), with or without temporary portocaval shunt (PCS) in the setting of liver transplantation. OBJECTIVES: To identify whether different cava anastomotic techniques and other maneuvers benefit the recipient regarding short-term outcomes and to provide international expert panel recommendations. DATA SOURCES: Ovid MEDLINE, Embase, Scopus, Google Scholar, and Cochrane Central. METHODS: A systematic review following PRISMA guidelines and recommendations using the GRADE approach derived from an international expert panel (CRD42021240979). RESULTS: Of 3205 records screened, 307 publications underwent full-text assessment for eligibility and 47 were included in qualitative synthesis. Four studies were randomized control trials. Eighteen studies were comparative. The remaining 25 were single-center retrospective noncomparative studies. CONCLUSION: Based on existing data and expert opinion, the panel cannot recommend one cava reconstruction technique over another, rather the surgical approach should be based on surgeon preference and center dependent, with special consideration toward patient circumstances (Quality of evidence: Low | Grade of Recommendation: Strong). The panel recommends against routine use of vevo-venous bypass (Quality of evidence: Very Low | Grade of Recommendation: Strong) and against the routine use of temporary porto-caval shunt (Quality of evidence: Very Low | Grade of Recommendation: Strong). ispartof: CLINICAL TRANSPLANTATION vol:36 issue:10 ispartof: location:Denmark status: published

Published
2022

30. Association between ezetimibe usage and hepatitis C RNA levels in uninfected kidney transplant recipients who received hepatitis C infected kidneys

Author

Azhar, Ambreen, primary, Binari, Laura A., additional, Joglekar, Kiran, additional, Tsujita, Makoto, additional, Talwar, Manish, additional, Balaraman, Vasanthi, additional, Bhalla, Anshul, additional, Eason, James D., additional, Hall, Isaac E., additional, Rofaiel, George, additional, Forbes, Rachel C., additional, Shaffer, David, additional, Concepcion, Beatrice P., additional, and Molnar, Miklos Z., additional

Published
2021
Full Text
View/download PDF

34. Rapamycin Alternatively Modifies Mitochondrial Dynamics in Dendritic Cells to Reduce Kidney Ischemic Reperfusion Injury

Author

Namwanje, Maria, primary, Bisunke, Bijay, additional, Rousselle, Thomas V., additional, Lamanilao, Gene G., additional, Sunder, Venkatadri S., additional, Patterson, Elizabeth C., additional, Kuscu, Canan, additional, Kuscu, Cem, additional, Maluf, Daniel, additional, Kiran, Manjari, additional, Mas, Valeria, additional, Eason, James D., additional, and Bajwa, Amandeep, additional

Published
2021
Full Text
View/download PDF

35. Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes

Author

Molnar, Miklos Z., primary, Azhar, Ambreen, additional, Tsujita, Makoto, additional, Talwar, Manish, additional, Balaraman, Vasanthi, additional, Bhalla, Anshul, additional, Podila, Pradeep S.B., additional, Kothadia, Jiten, additional, Agbim, Uchenna A., additional, Maliakkal, Benedict, additional, Satapathy, Sanjaya K., additional, Kovesdy, Csaba P., additional, Nair, Satheesh, additional, and Eason, James D., additional

Published
2021
Full Text
View/download PDF

37. Transplantation of liver from hepatitis C–infected donors to hepatitis C RNA–negative recipients: Histological and virologic outcome

Author

Nair, Satheesh P., primary, Marella, Hemnishil K., additional, Maliakkal, Benedict, additional, Snyder, Heather, additional, Handley, Charlotte, additional, Kothadia, Jiten P., additional, Ali, Bilal, additional, Satapathy, Sanjaya K., additional, Molnar, Miklos Z., additional, Clark, Ian, additional, Jain, Richa, additional, Helmick, Ryan, additional, Eymard, Corey, additional, and Eason, James D., additional

Published
2021
Full Text
View/download PDF

38. Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver Transplantation

Author

Satapathy, Sanjaya K., primary, Tran, Quynh T., additional, Kovalic, Alexander J., additional, Bontha, Sai Vineela, additional, Jiang, Yu, additional, Kedia, Satish, additional, Karri, Saradashri, additional, Mupparaju, Vamsee, additional, Podila, Pradeep S. B., additional, Verma, Rajanshu, additional, Maluf, Daniel, additional, Mas, Valeria, additional, Nair, Satheesh, additional, Eason, James D., additional, Bridges, Dave, additional, and Kleiner, David E., additional

Published
2021
Full Text
View/download PDF

40. MicroRNAs: Novel Targets in Hepatic Ischemia–Reperfusion Injury.

Author

Ingram, Holly, Dogan, Murat, Eason, James D., Kuscu, Cem, and Kuscu, Canan

Subjects
REPERFUSION injury, MICRORNA, LIVER transplantation, GRAFT rejection, THERAPEUTICS
Abstract

Hepatic ischemia–reperfusion injury (IRI) is one of the main factors for early allograft dysfunction (EAD), which may lead to graft rejection, graft loss, or shortened graft life in liver transplantation. Hepatic IRI appears to be inevitable during the majority of liver procurement and transportation of donor organs, resulting in a cascade of biological changes. The activation of signaling pathways during IRI results in the up- and downregulation of genes and microRNAs (miRNAs). miRNAs are ~21 nucleotides in length and well-characterized for their role in gene regulations; they have recently been used for therapeutic approaches in addition to their role as biomarkers for many diseases. miRNAs that are associated with hepatic IRI in in vitro and in vivo animal models are comprehensively summarized in this review. In those studies, the manipulation of miRNAs has been shown for the inhibition of aggravated immune response, reduction of apoptosis, stimulation of tissue repair, and enhancement of cell recovery to attenuate liver damage. Therefore, the utilization of liver-specific miRNA holds great potential as a therapeutic agent to improve early allograft dysfunction, hepatic injury, and patient outcome. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

42. Donor hepatitis C antibody positivity misclassifies kidney donor profile index in non‐hepatitis C‐infected donors: time to revise the kidney donor profile index – a retrospective cohort study

Author

Yazawa, Masahiko, primary, Balaraman, Vasanthi, additional, Tsujita, Makoto, additional, Azhar, Ambreen, additional, Talwar, Manish, additional, Bhalla, Anshul, additional, Potukuchi, Praveen K., additional, Eason, James D., additional, Kovesdy, Csaba P., additional, and Molnar, Miklos Z., additional

Published
2020
Full Text
View/download PDF

46. A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction

Author

Satapathy, Sanjaya K., primary, Gonzalez, Humberto C., additional, Vanatta, Jason, additional, Dyer, Andrew, additional, Angel, Wesley, additional, Nouer, Simonne S., additional, Kocak, Mehmet, additional, Kedia, Satish K., additional, Jiang, Yu, additional, Clark, Ian, additional, Yadak, Nour, additional, Nezakagtoo, Nosratollah, additional, Helmick, Ryan, additional, Horton, Peter, additional, Campos, Luis, additional, Agbim, Uchenna, additional, Maliakkal, Benedict, additional, Maluf, Daniel, additional, Nair, Satheesh, additional, Halford, Hollis H., additional, and Eason, James D., additional

Published
2020
Full Text
View/download PDF

48. Lack of Association between Pretransplant Donor-Specific Antibodies and Posttransplant Kidney Outcomes in Simultaneous Liver-Kidney Transplant Recipients with Rabbit Anti-Thymocyte Globulin Induction and Steroid-Free Protocol

Author

Yazawa, Masahiko, primary, Cseprekal, Orsolya, additional, Helmick, Ryan A., additional, Talwar, Manish, additional, Balaraman, Vasanthi, additional, Podila, Pradeep S.B., additional, Agbim, Uchenna A., additional, Maliakkal, Benedict, additional, Fossey, Sallyanne, additional, Satapathy, Sanjaya K., additional, Sumida, Keiichi, additional, Kovesdy, Csaba P., additional, Nair, Satheesh, additional, Eason, James D., additional, and Molnar, Miklos Z., additional

Published
2020
Full Text
View/download PDF

49. Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients

Author

Agbim, Uchenna, primary, Cseprekal, Orsolya, additional, Yazawa, Masahiko, additional, Talwar, Manish, additional, Balaraman, Vasanthi, additional, Bhalla, Anshul, additional, Podila, Pradeep S. B., additional, Maliakkal, Benedict, additional, Nair, Satheesh, additional, Eason, James D., additional, and Molnar, Miklos Z., additional

Published
2020
Full Text
View/download PDF

50. The incidence of cytomegalovirus infection after deceased-donor kidney transplantation from hepatitis-C antibody positive donors to hepatitis-C antibody negative recipients

Author

Yazawa, Masahiko, primary, Fülöp, Tibor, additional, Cseprekal, Orsolya, additional, Talwar, Manish, additional, Balaraman, Vasanthi, additional, Bhalla, Anshul, additional, Azhar, Ambreen, additional, Kovesdy, Csaba P., additional, Eason, James D., additional, and Molnar, Miklos Z., additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results